{
    "id": 27257,
    "fullName": "SEC61G - EGFR",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "SEC61G-EGFR results from the fusion of SEC61G and EGFR, and leads to ligand-independent, constitutive activation of Egfr signaling (PMID: 29092923). SEC61G-EGFR fusion has been identified in pediatric ependymomas (PMID: 29092923).",
            "references": [
                {
                    "id": 10317,
                    "pubMedId": 29092923,
                    "title": "Novel SEC61G-EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29092923"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 23480,
        "geneSymbol": "SEC61G",
        "terms": [
            "SEC61G",
            "SSS1"
        ]
    },
    "variant": "SEC61G - EGFR",
    "createDate": "11/14/2017",
    "updateDate": "11/14/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 1956,
                "geneSymbol": "EGFR",
                "terms": [
                    "EGFR",
                    "ERBB",
                    "ERBB1",
                    "HER1",
                    "mENA",
                    "NISBD2",
                    "PIG61"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 12316,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AEE788 inhibited Egfr signaling and growth of ependymoma cell lines harboring SEC61G-EGFR fusion in culture, resulted in prolonged survival in cell line xenograft models (PMID: 29092923).",
            "molecularProfile": {
                "id": 28676,
                "profileName": "SEC61G - EGFR"
            },
            "therapy": {
                "id": 622,
                "therapyName": "AEE788",
                "synonyms": null
            },
            "indication": {
                "id": 5509,
                "name": "pediatric ependymoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 10317,
                    "pubMedId": 29092923,
                    "title": "Novel SEC61G-EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29092923"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12317,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Iressa (gefitinib) inhibited Egfr signaling and growth of ependymoma cell lines harboring SEC61G-EGFR fusion in culture (PMID: 29092923).",
            "molecularProfile": {
                "id": 28676,
                "profileName": "SEC61G - EGFR"
            },
            "therapy": {
                "id": 751,
                "therapyName": "Gefitinib",
                "synonyms": null
            },
            "indication": {
                "id": 5509,
                "name": "pediatric ependymoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 10317,
                    "pubMedId": 29092923,
                    "title": "Novel SEC61G-EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29092923"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28676,
            "profileName": "SEC61G - EGFR",
            "profileTreatmentApproaches": [
                {
                    "id": 16604,
                    "name": "Gefitinib",
                    "profileName": "SEC61G - EGFR"
                },
                {
                    "id": 16605,
                    "name": "AEE788",
                    "profileName": "SEC61G - EGFR"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}